These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 38690211)

  • 1. Advancing liposome technology for innovative strategies against malaria.
    Miatmoko A; Octavia RT; Araki T; Annoura T; Sari R
    Saudi Pharm J; 2024 Jun; 32(6):102085. PubMed ID: 38690211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
    Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
    Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal Drug Delivery and Its Potential Impact on Cancer Research.
    Bhattacharya S; Saindane D; Prajapati BG
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2671-2683. PubMed ID: 35440318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches.
    Kansız S; Elçin YM
    Adv Colloid Interface Sci; 2023 Jul; 317():102930. PubMed ID: 37290380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.
    Nikolova MP; Kumar EM; Chavali MS
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivesicular Liposome: A Lipid-based Drug Delivery System for Efficient Drug Delivery.
    Gorain B; Al-Dhubiab BE; Nair A; Kesharwani P; Pandey M; Choudhury H
    Curr Pharm Des; 2021; 27(43):4404-4415. PubMed ID: 34459377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-polymer complex for drug delivery system and vaccine stabilization.
    Sriwidodo ; Umar AK; Wathoni N; Zothantluanga JH; Das S; Luckanagul JA
    Heliyon; 2022 Feb; 8(2):e08934. PubMed ID: 35243059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pros and cons of the liposome platform in cancer drug targeting.
    Gabizon AA; Shmeeda H; Zalipsky S
    J Liposome Res; 2006; 16(3):175-83. PubMed ID: 16952872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes for malaria management: the evolution from 1980 to 2020.
    Memvanga PB; Nkanga CI
    Malar J; 2021 Jul; 20(1):327. PubMed ID: 34315484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining critical parameters that influence in vitro performance characteristics of a thermosensitive liposome formulation of vinorelbine.
    Regenold M; Steigenberger J; Siniscalchi E; Dunne M; Casettari L; Heerklotz H; Allen C
    J Control Release; 2020 Dec; 328():551-561. PubMed ID: 32896612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective-Loading of Platinum-Chloroquine into PEGylated Neutral and Cationic Liposomes as a Drug Delivery System for Resistant Malaria Parasites.
    Ibrahim S; Tagami T; Ozeki T
    Biol Pharm Bull; 2017; 40(6):815-823. PubMed ID: 28566625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro.
    Urbán P; Estelrich J; Cortés A; Fernàndez-Busquets X
    J Control Release; 2011 Apr; 151(2):202-11. PubMed ID: 21223986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome technologies towards colorectal cancer therapeutics.
    Sang R; Stratton B; Engel A; Deng W
    Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of liposomes as drug delivery system for therapeutic applications.
    Guimarães D; Cavaco-Paulo A; Nogueira E
    Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.